Back to Search Start Over

Surgical Treatment of Hepatocellular Carcinoma: Multicenter Competing-risk Analysis of Tumor-related Death Following Liver Resection and Transplantation Under an Intention-to-treat Perspective

Authors :
Di Sandro, S
Sposito, C
Ravaioli, M
Lauterio, A
Magistri, P
Bongini, M
Odaldi, F
De Carlis, R
Botta, F
Centonze, L
Maroni, L
Citterio, D
Guidetti, C
Bagnardi, V
De Carlis, L
Cescon, M
Mazzaferro, V
Di Benedetto, F
Catellani, B
Piero Guerrini, G
Danieli, M
Frassoni, S
Virdis, M
Bhoori, S
Serenari, M
Laurenzi, A
Di Sandro S.
Sposito C.
Ravaioli M.
Lauterio A.
Magistri P.
Bongini M.
Odaldi F.
De Carlis R.
Botta F.
Centonze L.
Maroni L.
Citterio D.
Guidetti C.
Bagnardi V.
De Carlis L.
Cescon M.
Mazzaferro V.
Di Benedetto F.
Catellani B.
Piero Guerrini G.
Danieli M.
Frassoni S.
Virdis M.
Bhoori S.
Serenari M.
Laurenzi A.
Di Sandro, S
Sposito, C
Ravaioli, M
Lauterio, A
Magistri, P
Bongini, M
Odaldi, F
De Carlis, R
Botta, F
Centonze, L
Maroni, L
Citterio, D
Guidetti, C
Bagnardi, V
De Carlis, L
Cescon, M
Mazzaferro, V
Di Benedetto, F
Catellani, B
Piero Guerrini, G
Danieli, M
Frassoni, S
Virdis, M
Bhoori, S
Serenari, M
Laurenzi, A
Di Sandro S.
Sposito C.
Ravaioli M.
Lauterio A.
Magistri P.
Bongini M.
Odaldi F.
De Carlis R.
Botta F.
Centonze L.
Maroni L.
Citterio D.
Guidetti C.
Bagnardi V.
De Carlis L.
Cescon M.
Mazzaferro V.
Di Benedetto F.
Catellani B.
Piero Guerrini G.
Danieli M.
Frassoni S.
Virdis M.
Bhoori S.
Serenari M.
Laurenzi A.
Publication Year :
2023

Abstract

Background. Early-stage hepatocellular carcinoma could benefit from upfront liver resection (LR) or liver transplantation (LT), but the optimal strategy in terms of tumor-related outcomes is still debated. We compared the oncological outcomes of LR and LT for hepatocellular carcinoma, stratifying the study population into a low-, intermediate-, and high-risk class according to the risk of death at 5-y predicted by a previously developed prognostic model. The impact of tumor pathology on oncological outcomes of low- and intermediate-risk patients undergoing LR was investigated as a secondary outcome. Methods. We performed a retrospective multicentric cohort study involving 2640 patients consecutively treated by LR or LT from 4 tertiary hepatobiliary and transplant centers between 2005 and 2015, focusing on patients amenable to both treatments upfront. Tumor-related survival and overall survival were compared under an intention-to-treat perspective. Results. We identified 468 LR and 579 LT candidates: 512 LT candidates underwent LT, whereas 68 (11.7%) dropped-out for tumor progression. Ninety-nine high-risk patients were selected from each treatment cohort after propensity score matching. Three and 5-y cumulative incidence of tumor-related death were 29.7% and 39.5% versus 17.2% and 18.3% for LR and LT group (P = 0.039), respectively. Low-risk and intermediate-risk patients treated by LR and presenting satellite nodules and microvascular invasion had a significantly higher 5-y incidence of tumor-related death (29.2% versus 12.5%; P < 0.001). Conclusions. High-risk patients showed significantly better intention-to-treat tumor-related survival after upfront LT rather than LR. Cancer-specific survival of low- and intermediate-risk LR patients was significantly impaired by unfavorable pathology, suggesting the application of ab-initio salvage LT in such scenarios.

Details

Database :
OAIster
Notes :
STAMPA, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1434546138
Document Type :
Electronic Resource